Recently, the CRP/Alb ratio has been reported to be a prognostic predictor in patients with hepatocellular carcinoma [55] and patients with UICC stage III or IV PDAC with a cut-off value of 0.54 [6]. This evidence concerns the gene CRP and hepatocellular carcinoma.